202 related articles for article (PubMed ID: 2170479)
21. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
Grant SM; Clissold SP
Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
[TBL] [Abstract][Full Text] [Related]
22. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis.
Catanzaro A; Cloud GA; Stevens DA; Levine BE; Williams PL; Johnson RH; Rendon A; Mirels LF; Lutz JE; Holloway M; Galgiani JN
Clin Infect Dis; 2007 Sep; 45(5):562-8. PubMed ID: 17682989
[TBL] [Abstract][Full Text] [Related]
23. Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules.
Saul A; Bonifaz A
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):554-8. PubMed ID: 2170473
[TBL] [Abstract][Full Text] [Related]
24. Large-Scale Evaluation of
Thompson GR; Barker BM; Wiederhold NP
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
[TBL] [Abstract][Full Text] [Related]
25. Adverse events associated with itraconazole in 189 patients on chronic therapy.
Tucker RM; Haq Y; Denning DW; Stevens DA
J Antimicrob Chemother; 1990 Oct; 26(4):561-6. PubMed ID: 2174854
[TBL] [Abstract][Full Text] [Related]
26. Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.
Thompson GR; Lewis JS; Nix DE; Patterson TF
Med Mycol; 2019 Feb; 57(Supplement_1):S76-S84. PubMed ID: 30690601
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic optimisation of oral antifungal therapy.
Schäfer-Korting M
Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
[TBL] [Abstract][Full Text] [Related]
28. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
Denning DW; Tucker RM; Hanson LH; Stevens DA
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):602-7. PubMed ID: 2170480
[TBL] [Abstract][Full Text] [Related]
29. Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA
Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949
[TBL] [Abstract][Full Text] [Related]
30. Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas.
Ramani R; Chaturvedi V
Mycopathologia; 2007 Jun; 163(6):315-9. PubMed ID: 17484074
[TBL] [Abstract][Full Text] [Related]
31. Coccidioidomycosis: efficacy of new agents and future prospects.
Deresinski SC
Curr Opin Infect Dis; 2001 Dec; 14(6):693-6. PubMed ID: 11964886
[TBL] [Abstract][Full Text] [Related]
32. Azole therapy of clinical and experimental coccidioidomycosis.
Stevens DA; Clemons KV
Ann N Y Acad Sci; 2007 Sep; 1111():442-54. PubMed ID: 17344535
[TBL] [Abstract][Full Text] [Related]
33. A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis.
Levine HB
Sabouraudia; 1984; 22(1):37-46. PubMed ID: 6322362
[TBL] [Abstract][Full Text] [Related]
34. Primary Cutaneous Coccidioidomycosis of the Eyelid: A Case Report.
Dworak DP; Kapustiak J; Ehklassi TA; Patrianakos TD
Ophthalmic Plast Reconstr Surg; 2016; 32(2):e40-1. PubMed ID: 25072222
[TBL] [Abstract][Full Text] [Related]
35. Azole antifungal drugs in treatment of coccidioidomycosis.
Graybill JR
Semin Respir Infect; 1986 Mar; 1(1):53-60. PubMed ID: 3317599
[TBL] [Abstract][Full Text] [Related]
36. Refractory coccidioidomycosis treated with posaconazole.
Anstead GM; Corcoran G; Lewis J; Berg D; Graybill JR
Clin Infect Dis; 2005 Jun; 40(12):1770-6. PubMed ID: 15909265
[TBL] [Abstract][Full Text] [Related]
37. Azole antifungal drugs: old and new.
Dismukes WE
Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
[No Abstract] [Full Text] [Related]
38. Treatment of coccidioidomycosis with SCH 39304.
Hostetler JS; Catanzaro A; Stevens DA; Graybill JR; Sharkey PK; Larsen RA; Tucker RM; al-Haidary AD; Rinaldi MG; Cloud GA
J Med Vet Mycol; 1994; 32(2):105-14. PubMed ID: 8064541
[TBL] [Abstract][Full Text] [Related]
39. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.
Van Peer A; Woestenborghs R; Heykants J; Gasparini R; Gauwenbergh G
Eur J Clin Pharmacol; 1989; 36(4):423-6. PubMed ID: 2544431
[TBL] [Abstract][Full Text] [Related]
40. Treatment of invasive aspergillosis with itraconazole.
Denning DW; Tucker RM; Hanson LH; Stevens DA
Am J Med; 1989 Jun; 86(6 Pt 2):791-800. PubMed ID: 2543220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
